Roche suffers third delay on Spark deal
Roche’s acquisition of Spark was announced at the start of the year but closing the deal has proved difficult after a third delay incurred to give the FTC extra review time.
Archives for May 16, 2019
WuXi Biologics to build 1.3m-sq-ft manufacturing centre
WuXi Biologics announces its latest expansion, with plans for a drug development and commercial manufacturing site with a potential bioreactor capacity of 144,000L.